SAN FRANCISCO — McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately. Walchirk, who most recently was chief operating officer of McKesson Specialty Health, has held numerous leadership roles at McKesson over the past 11 years, including COO of McKesson U.S. Pharmaceutical.
